3 assets in Postmenopausal Atrophic Vaginitis

Therapeutic assets addressing Postmenopausal Atrophic Vaginitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dehydroepiandrosterone Postmenopausal Atrophic Vaginitis	University Hospital, Ghent	P4	BB (66)
Autologous Conditioned Plasma Postmenopausal Atrophic Vaginitis	University of Miami	P2	B (60)
Promestriene Postmenopausal Atrophic Vaginitis	Federal University of São Paulo	N/A	D (30)